Dr. Machleidt currently leads the cell biology team within the Advanced Technology Group. His main interest is the development and application of novel technology platforms for the analysis of protein dynamics in cells. Dr. Machleidt earned his M.S. in Biology from the Eberhardt Karls University in Tuebingen. He received his Ph.D. in Immunology for his work on the signaling mechanisms of the pro-inflammatory cytokine TNF in Prof. Kronke’s lab at the Technical University of Munich. For his postdoc he joined the lab of RGW Anderson at UT Southwestern Medical Center where he investigated the structure and function of the caveolin protein family. He subsequently held R&D positions at Johnson & Johnson and Ansata Therapeutics. Prior to joining Promega in 2011 he worked as a group leader for 7 years at Life Technologies. Dr. Machleidt has authored and co-authored 48 peer reviewed publications and book chapters.